Showing 6,074 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP

Women need more of the HIV drug Truvada than men to prevent infection

Editor's pick
Eurekalert Medicine & Health
4 March 2016
PrEP science

Maraviroc may work as PrEP in combination with another drug – but probably not by itself

News
3 March 2016
PrEP

San Francisco HIV providers: What did you learn at CROI 2016?

Editor's pick
BETA blog
3 March 2016
New & experimental HIV treatments

ABIVAX’s Novel Approach to Treat HIV Demonstrates Safety and Preliminary Anti-viral Activity in Phase IIa

Editor's pick
Abivax press release
2 March 2016
Finding support

Dumbing Down Treatment Decisions, Part Two

Editor's pick
Positive Lite
2 March 2016
New & experimental HIV treatments

Gilead Sciences Announces FDA Approval of Odefsey as HIV-1 Treatment in Certain Patients

Editor's pick
Gilead press release
2 March 2016
Retention & linkage to care

Rate of entry into HIV care improved by personalised counselling

News
1 March 2016
Retention & linkage to care

Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

News
1 March 2016
Vaginal rings & topical PrEP

Vaginal ring for HIV prevention: a few details would have elevated good coverage to great

Editor's pick
Health News Review
1 March 2016
The search for a cure

Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption

News
29 February 2016
Treatment outcomes & life expectancy

Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people

News
28 February 2016
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine/Tenofovir Alafenamide) for the Treatment of HIV

Editor's pick
Gilead press release
26 February 2016
The search for a cure

Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016

Editor's pick
Sangamo Biosciences press release
26 February 2016
PrEP

Dr. Robert Grant weighs in after the first case of failed PrEP: What does it mean?

Editor's pick
BETA blog
26 February 2016
PrEP science

Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016

News
25 February 2016
Cancer

Early antiretroviral therapy reduces the risk of infection-related cancers

News
25 February 2016
Starting treatment

Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day

News
25 February 2016
HIV treatment for children & young people

Dolutegravir safe and highly effective in older children

News
25 February 2016
New & experimental HIV treatments

TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity

News
25 February 2016
PrEP

What is a drug “tail,” and what does it have to do with long-acting PrEP?

Editor's pick
BETA blog
25 February 2016
Hepatitis C treatment

New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

Editor's pick
World Health Organization
25 February 2016
Global health targets

Botswana close to reaching the 90-90-90 testing and treatment targets

News
25 February 2016
Starting treatment

Starting HIV treatment at first clinic visit improves outcomes in African study

News
24 February 2016
New & experimental HIV treatments

Gilead announces results from first study to evaluate switching to FTAF-based regimens from Truvada® (FTDF)-based regimens

Editor's pick
Gilead press release
24 February 2016